Table 1.
Overall (N=400) | With Ocular Symptoms n=38 | No Ocular Symptoms n=362 | P-value | |
---|---|---|---|---|
Age, mean (SD), y | 61.7 (15.5) | 59.2 (16.0) | 61.9 (15.4) | 0.2529 |
Male, No. (%) | 233 (58.3) | 26 (68.4) | 207 (57.2) | 0.1814 |
Fever, No. (%) | 259 (64.8) | 29 (76.3) | 230 (63.5) | 0.1167 |
Prior ocular history, No. (%) | 77 (19.3) | 11 (29.0) | 66 (18.2) | 0.1110 |
Mechanical ventilation, No. (%) | 157 (39.3) | 18 (47.4) | 139 (38.4) | 0.2813 |
Disposition, No. (%) | ||||
Home | 257 (64.3) | 27 (71.1) | 230 (63.5) | 0.6249 |
Facility | 71 (17.8) | 6 (15.8) | 65 (18.0) | |
Hospice/Deceased | 72 (18.0) | 5 (13.2) | 67 (18.5) | |
CRPa, mg/dL | 9.5 (5.7, 14.5) | 9.6 (6.7, 14.5) | 9.4 (5.6, 14.6) | 0.5265 |
D-Dimera, mg/L | 1.8 (0.9, 5.3) | 1.8 (1.0, 4.6) | 1.8 (0.9, 5.3) | 0.9919 |
Ferritina, ng/mL | 942.1 (435.9, 1499.4) | 777.4 (532.1, 1646.2) | 944.7 (435.9, 1473.8) | 0.9008 |
ALCa, K/uL | 1.1 (0.8, 1.5) | 1.0 (0.8, 1.5) | 1.1 (0.9, 1.5) | 0.5400 |
Notes: aCRP, D-Dimer, Ferritin, and ALC shown as median (IQR). Comparison between the 2 groups was performed using the chi-square test or Fisher exact test for categorical variables and the Wilcoxon rank-sum test for continuous variables.
Abbreviations: COVID-19, coronavirus disease 2019; SD, standard deviation; CRP, C-reactive protein; ALC, absolute lymphocyte count.